RE:Why do you hate Pozen so much?Yosprala approval taking so long. Low organic growth compared to Tribute making Tribute worth as much if not more than Pozen. So the grumbling is that share allocations should be more equitable and the deal should be revised given current valuations.
I think it's nothing against Pozen itself. With Yosprala approval it has the potential to be very big but it's taken years so far so there is some well deserved skepticism.